Provided by Tiger Trade Technology Pte. Ltd.

Compass Therapeutics, Inc.

6.17
-0.2200-3.44%
Pre-market: 6.170.00000.00%08:35 EST
Volume:1.36M
Turnover:8.43M
Market Cap:1.10B
PE:-13.67
High:6.43
Open:6.31
Low:6.14
Close:6.39
52wk High:6.88
52wk Low:1.33
Shares:177.86M
Float Shares:123.05M
Volume Ratio:0.82
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4512
EPS(LYR):-0.3594
ROE:-37.82%
ROA:-23.47%
PB:5.24
PE(LYR):-17.17

Loading ...

Aug 01, 2022

Major Issues Report

8-K - Current report
May 31, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2022

Major Issues Report

8-K - Current report
Apr 26, 2022

Major Issues Report

8-K - Current report
Mar 18, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2022

Major Issues Report

8-K - Current report
Dec 30, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2021

Major Issues Report

8-K - Current report
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 01, 2021

Major Issues Report

8-K - Current report
Oct 08, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jul 16, 2021

Correspondence

CORRESP [Cover] - Correspondence